Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kane Biotech Inc Ord (KNBIF)

Kane Biotech Inc Ord (KNBIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.03
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0203 +5.42%
on 03/19/26
0.0239 -10.46%
on 03/18/26
-0.0047 (-18.01%)
since 03/17/26
3-Month
0.0203 +5.42%
on 03/19/26
0.0338 -36.69%
on 01/28/26
-0.0072 (-25.17%)
since 01/16/26
52-Week
0.0203 +5.42%
on 03/19/26
0.0676 -68.34%
on 04/25/25
-0.0453 (-67.92%)
since 04/17/25

Most Recent Stories

More News
Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference

>20 year‑old venous leg ulcers show dramatic healing and pain elimination with revyve Thermoreversible revyve transforms deep tunneling wound care, delivering 90% wound volume reduction revyve...

KNE.VN : 0.030 (-14.29%)
KNBIF : 0.0214 (+0.94%)
Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms

WINNIPEG, Manitoba, March 17, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech” or “Kane”) announces that Frontiers in Antibiotics has published a peer-reviewed article...

KNE.VN : 0.030 (-14.29%)
KNBIF : 0.0214 (+0.94%)
Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership

WINNIPEG, Manitoba, March 10, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (Kane or the Company), transforming wound care with three FDA 510(k) cleared and two Health Canada approved formats, is pleased...

KNE.VN : 0.030 (-14.29%)
KNBIF : 0.0214 (+0.94%)
Kane Biotech Announces Publication of revyve® Wound Gel Article in the International Wound Journal

WINNIPEG, Manitoba, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE) (“Kane Biotech” or “Kane”) announces the publication of an article on its revyve ® Antimicrobial wound gel...

KNE.VN : 0.030 (-14.29%)
KNBIF : 0.0214 (+0.94%)
Kane Biotech Expands Commercial Activities in the United States

WINNIPEG, Manitoba, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech” or the “Company”) today announces that it has signed non-exclusive distribution/sales agreements...

KNE.VN : 0.030 (-14.29%)
KNBIF : 0.0214 (+0.94%)
Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial Skin and Wound Cleanser

WINNIPEG, Manitoba, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSXV:KNE) (“Kane Biotech”. “Kane” or the “Company”) today announces two regulatory milestones that strengthen the...

KNE.VN : 0.030 (-14.29%)
KNBIF : 0.0214 (+0.94%)
Kane Biotech Restarts Commercial Activities and Strengthens North American Management

WINNIPEG, Manitoba, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces the resumption of commercial activities in both...

KNE.VN : 0.030 (-14.29%)
KNBIF : 0.0214 (+0.94%)
Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company

WINNIPEG, Manitoba, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces that today it has completed its previously announced...

KNE.VN : 0.030 (-14.29%)
KNBIF : 0.0214 (+0.94%)
Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting

WINNIPEG, Manitoba, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) announces that it presented new clinical and scientific data...

KNE.VN : 0.030 (-14.29%)
KNBIF : 0.0214 (+0.94%)
Kane Biotech Receives Health Canada Approval for revyve® Antimicrobial Wound Gel Spray

WINNIPEG, Manitoba, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces that Health Canada has approved its revyve ®...

KNE.VN : 0.030 (-14.29%)
KNBIF : 0.0214 (+0.94%)

Business Summary

Kane Biotech Inc. is a biotechnology company formed in 2001. It is involved in research and development of products to prevent and disperse biofilms. It uses a patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms....

See More

Key Turning Points

3rd Resistance Point 0.0217
2nd Resistance Point 0.0217
1st Resistance Point 0.0215
Last Price 0.0214
1st Support Level 0.0213
2nd Support Level 0.0213
3rd Support Level 0.0211

See More

52-Week High 0.0676
Fibonacci 61.8% 0.0495
Fibonacci 50% 0.0439
Fibonacci 38.2% 0.0384
Last Price 0.0214
52-Week Low 0.0203

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.